1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Belgium Pharmaceuticals and Healthcare Report Q1 2017

Belgium Pharmaceuticals and Healthcare Report Q1 2017

  • November 2016
  • -
  • Business Monitor International
  • -
  • 86 pages

Includes 3 FREE quarterly updates


>BMI View:
Belgium offers a stable pharmaceutical market with high per capita spending on medicines. However, heightened political uncertainty and a regional economic downturn will overshadow Belgium's economic outlook for the foreseeable future. In the near term, the prospect of a 'hard Brexit', in which the UK reaches no deal with the EU for preferential access to the common market, poses the greatest risk to healthcare and wider economic growth.

Headline Expenditure Projections

- Pharmaceuticals: From EUR5.84bn (USD6.47bn) in 2015 to EUR5.89bn (USD6.30bn) in 2016; +1.0% in local currency terms and -2.6% in US dollar terms.

- Healthcare: From EUR42.12bn (USD46.72bn) in 2015 to EUR43.06bn (USD46.07bn) 2016; +2.2% in local currency terms and -1.4% in US dollar terms. In BMI's Q117 Western European Risk/Reward Index (RRI), Belgium scores 68.8 out of 100, dropping the country to ninth position out of the 15 markets in the region from last quarter. Belgium performs well in the Rewards category on account of its high per capita drug consumption, but is closer to the regional average in terms of Risk due to its high levels of government bureaucracy.

Table Of Contents

Belgium Pharmaceuticals and Healthcare Report Q1 2017
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Belgium 2014-2020) 7
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Belgium 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Belgium 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Belgium 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Belgium 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Belgium 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Belgium 2012-2020) 23
Generc Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belgium 2012-2020) 26
OTC Medicine Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Belgium 2012-2020) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (Belgium 2014-2020) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Belgium 2014-2020) 32
Industry Risk/Reward Index 33
Western Europe Risk/Reward Index 33
Belgium Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Intellectual Property Issues 42
Pricing Regime 42
Reimbursement Regime 44
Table: Reimbursements by Category, 2009 46
Table: Price Build-Up for OTC Medicines 48
Market Overview 49
Healthcare Sector 49
Table: Healthcare Resources (Belgium 2010-2015) 51
Table: Healthcare Personnel (Belgium 2010-2015) 52
Table: Healthcare Activity (Belgium 2010-2015) 52
Research and Development 54
Clinical Trials 54
Epidemiology 56
Competitive Landscape 59
Research-Based Industry 59
Table: Multinational Market Activity 60
Pharmaceutical Distribution 62
Pharmaceutical Retail Sector 62
Company Profile 64
Galapagos 64
Janssen Pharmaceutica 68
UCB Pharma 71
Demographic Forecast 75
Table: Population Headline Indicators (Belgium 1990-2025) 76
Table: Key Population Ratios (Belgium 1990-2025) 76
Table: Urban/Rural Population and Life Expectancy (Belgium 1990-2025) 77
Table: Population By Age Group (Belgium 1990-2025) 77
Table: Population By Age Group % (Belgium 1990-2025) 78
Glossary 80
Methodology 82
Pharmaceutical Expenditure Forecast Model 82
Healthcare Expenditure Forecast Model 82
Notes On Methodology 83
Risk/Reward Index Methodology 84
Index Overview 85
Table: Pharmaceutical Risk/Reward Index Indicators 85
Indicator Weightings 86

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.